CGM097
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Solid Tumor With p53 Wild Type Status
Conditions
Solid Tumor With p53 Wild Type Status
Trial Timeline
Mar 20, 2013 → Jul 24, 2020
NCT ID
NCT01760525About CGM097
CGM097 is a phase 1 stage product being developed by Novartis for Solid Tumor With p53 Wild Type Status. The current trial status is completed. This product is registered under clinical trial identifier NCT01760525. Target conditions include Solid Tumor With p53 Wild Type Status.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01760525 | Phase 1 | Completed |
Competing Products
20 competing products in Solid Tumor With p53 Wild Type Status